Kojin Therapeutics

Our Scientific Advisory Board is an active group of founders, advisors, and collaborators, each of whom adds to Kojin’s continued progress in developing innovative, small-molecule medicines based on #ferroptosis human biology for patients with cancer, immune and inflammatory disease, and other difficult-to-treat conditions. We are grateful for their expert insights and commitment to our mission. Learn more about Kojin’s scientific foundations and SAB at https://kojintx.com/. Stuart Schreiber, Ben Cravatt, Sean Morrison, Joel Barrish, Morris Birnbaum, Steve Davidsen, George Demetri, Benjamin Neel, Eric Winer, MD, FASCO, Stephanie Dougan #redox #chemicalbiology #cancer #immunology #inflammation #metabolism #celldeath #lipidomics #biotech

Kojinites Sneha Basak, PhD and Ayesha M. Patel, PhD recently headed north to New Hampshire to attend the Enzymes, Coenzymes and Metabolic Pathways Gordon Research Conferences, “New Methods in Enzymology and Chemical Biology to Aid the Study of Mechanisms and Metabolic Pathways." The conference highlighted a broad range of topics from chemical biology, biocatalysis, mechanism and function of enzymes, to therapeutic applications in enzymology. Kojin is proud to provide professional development opportunities that help team members gain new skills to bring to their important and innovative work in drug discovery. We’re hiring! #ferroptosis #enzymology #cancerresearch #biotech #drugdiscovery #hiring

Stuart Schreiber, our founding SAB chair, has a special view of our drug discovery, having led the initial work on defining ferroptosis susceptibility of certain cancers while at the Broad Institute of MIT and Harvard. He joins us in welcoming Drs. Eric Winer, MD, FASCO and Benjamin Neel to our SAB to help guide us forward in developing medicines for patients with cancer and other challenging diseases. #ferroptosis #cancerresearch #cancer #tumors #biotech #drugdiscovery Arena BioWorks

Dr. Eric Winer, a leader in the field of medical oncology, has joined Kojin’s SAB. He is renowned for his patient-centric approach to clinical care and research. Dr. Winer is a member of the Board and Past President of the American Society of Clinical Oncology (ASCO) and a member of the Scientific Advisory Board of the Breast Cancer Research Foundation; he co-led the NCI Breast Cancer Steering Committee. Dr. Winer brings a wealth of clinical-research experience to Kojin, and we look forward to his insights as we develop a portfolio of #ferroptosis modulating medicines for patients with #cancer. #oncology #breastcancer #drugdiscovery #biotech #startup #healthcare #redoxbiology. To learn more about Dr. Winer, check out https://lnkd.in/ekajqFvm

We extend a warm welcome to Dr. Benjamin G. Neel, Professor of Medicine at NYU Grossman School of Medicine, who has joined our Scientific Advisory Board. His expertise in cancer biology, cell signaling, and large-scale genomic analysis will add to our continued growth in developing novel treatments for patients with cancer and other difficult-to-treat diseases. Welcome, Dr. Neel! #ferroptosis #oncology #breastcancer #ovariancancer #drugdiscovery #biotech #startup #healthcare. To learn more about Dr. Neel, check out www.theneellab.com.

Kojin Therapeutics is #Hiring. We are looking for a team member with deep knowledge of state-of-the-art computational chemistry techniques, deployed to accelerate small-molecule drug discovery. Learn more about this position here: https://bit.ly/3QKoSfx #Chemists #Biotech

We are looking for talented #Pharmacologists to work in our #collaborative environment advancing novel small-molecule therapeutics that modulate ferroptosis. View our open roles for Preclinical In Vivo and Molecular Pharmacologists: https://bit.ly/4aL0eDv #Hiring #biotech

Kojin Therapeutics is hiring Medicinal/Organic Chemists. Learn more about the positions and our team harnessing groundbreaking discoveries in cell-state and ferroptosis biology: https://bit.ly/3JZFWKL #hiring #Biotech #Chemists

Become a ferroptosis pioneer at Kojin Therapeutics. Join our growing scientific team and help lead the way in developing new #cancer medicines that induce #ferroptosis. #biotech #drugdiscovery

We are hiring Molecular Cell Biologists and Chemical Biologists. Join the innovative Kojin Therapeutics #drugdiscovery team developing first-in-class medicines for patients with #cancer and other difficult-to-treat diseases. Apply now: https://bit.ly/4aobQv3 #hiring #biotech #biologists